(Q46202262)

20 December 2017

title

Ras activation in human breast cancer (English)

1 reference

20 December 2017

author name string

von Lintig FC

1

1 reference

20 December 2017

Dreilinger AD

2

1 reference

20 December 2017

Varki NM

3

1 reference

20 December 2017

Wallace AM

4

1 reference

20 December 2017

Casteel DE

5

1 reference

20 December 2017

Boss GR

6

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

20 December 2017

Breast Cancer Research and Treatment

published in

1 reference

20 December 2017

volume

62

1 reference

20 December 2017

page(s)

51-62

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1023/a:1006491619920

exact match

0 references

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Molecular insights into breast cancer from transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Aberrant function of the Ras signal transduction pathway in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

CSF-1 and its receptor in ovarian, endometrial and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Hyperexpression of mitogen-activated protein kinase in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Proliferation of human malignant astrocytomas is dependent on Ras activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Assay for nanogram quantities of DNA in cellular homogenates

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Biological and biochemical properties of human rasH genes mutated at codon 61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Two erbB-4 transcripts are expressed in normal breast and in most breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

inferred from DOI database lookup

7 January 2021

based on heuristic

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

inferred from DOI database lookup

7 January 2021

based on heuristic

Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006491619920

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1023/A:1006491619920

1 reference

20 December 2017

Dimensions Publication ID

0 references

1 reference

20 December 2017